InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.23
(
0.77%
)
US TECH 100
19,430.00
(
0.14%
)
Dow Jones
38,778.10
(
0.49%
)
Brent Oil
83.54
(
-0.44%
)
Bitcoin
65,641.04
(
-1.27%
)
Post# of 699224
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Doc logic

Send PM Follow Ignore
Followers 163
Posts 12871
Boards Moderated 1
Alias Born 01/26/2016

Doc logic

Re: flipper44 post# 59672

Monday, 04/25/2016 8:36:35 PM

Monday, April 25, 2016 8:36:35 PM

Post# of 699224
flipper44,

I agree with your conclusions. DCVax-L (primer 1) as is will be used to prime an immune response to the newest neoantigens. Then the responding T-cells will be harvested and cloned for use as an adjunct combination therapy or neoantigens will be identified, separated and those that cause the best T-cell response will be presented to DCs to create DCVax-L (primer 2). The harvested T-cells approach is being tested now and results should be known within 1 year. My understanding is that the neoantigens primed DC approach has yet to be tested.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News
InvestorsHub NewsWire

Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM

ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM

Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM

Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM

HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM

Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM

Start posting your company's news
Only $200 per official company press release!